Financial Results for 3Q FY2016 (April 1 to December 31, 2016)

Sumitomo Dainippon Pharma Co., Ltd.

Representative Director,
Senior Executive Vice President
Drug Research; Drug Development; Technology Research & Development; Regenerative & Cellular Medicine; Global Oncology
Hiroshi Noguchi

Member, Board of Directors, Executive Vice President
External Affairs; Corporate Secretariat & Industry Affairs; Finance & Accounting; Drug Development Division; Special Assignments
Hiroshi Nomura

Member, Board of Directors, Executive Officer
Senior Director, Global Corporate Planning; Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center
Toru Kimura